Edition:
United Kingdom

OHR Pharmaceutical Inc (OHRP.OQ)

OHRP.OQ on NASDAQ Stock Exchange Capital Market

0.26USD
5:42pm GMT
Change (% chg)

$0.01 (+5.02%)
Prev Close
$0.25
Open
$0.25
Day's High
$0.26
Day's Low
$0.24
Volume
21,820
Avg. Vol
440,243
52-wk High
$2.17
52-wk Low
$0.24

Chart for

About

Ohr Pharmaceutical, Inc. is a pharmaceutical company focused on the development of therapeutics and delivery technologies for the treatment of ocular disease. The Company's development pipeline consists of several programs and indications at various stages of development. Its product pipeline includes Squalamine Lactate... (more)

Overall

Beta: 0.36
Market Cap(Mil.): $39.03
Shares Outstanding(Mil.): 56.21
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Ohr Pharmaceutical Q1 Loss Per Share $0.07

* OHR PHARMACEUTICAL REPORTS FISCAL FIRST QUARTER 2018 FINANCIAL RESULTS

14 Feb 2018

BRIEF-Ohr Pharmaceutical Announces Efficacy Results From The Mako Study In Wet-Amd

* OHR PHARMACEUTICAL ANNOUNCES EFFICACY RESULTS FROM THE MAKO STUDY IN WET-AMD

05 Jan 2018

BRIEF-OHR Pharmaceutical Reports Fiscal Year 2017 Financial Results

* OHR PHARMACEUTICAL REPORTS FISCAL YEAR 2017 FINANCIAL RESULTS

15 Dec 2017

BRIEF-Ohr Pharmaceutical files for mixed shelf of up to $250 mln

* Files for mixed shelf of up to $250 million - SEC filing‍​ Source text: (http://bit.ly/2x8VRBB) Further company coverage:

15 Sep 2017

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF222.05 -1.25
Roche Holding Ltd. (RO.S) CHF225.80 -0.60
Regeneron Pharmaceuticals Inc (REGN.OQ) $319.69 +3.87
Amgen, Inc. (AMGN.OQ) $183.97 +1.52
Novartis AG (NOVN.S) CHF79.38 -0.60
Allergan plc (AGN.N) $161.71 +2.31

Earnings vs. Estimates